Session Details
[GS03☆]Materializing Pharmaceutical Learning: Young Researchers Tackling Challenges from Disease Mechanisms to Clinical Solutions
Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 09 (B401, Bldg. 1, Area 2 [4F])
Organizer: Takayoshi Kawabata (Dept. Pharm., Okayama Univ. Hosp., Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ.), Shuto Itokazu (Dept. of Clin. Pharmacol. & Ther., Grad. Sch. Biomed. Sci., Tokushima Univ.)
The field of pharmacy encompasses a broad spectrum, from understanding disease states to developing pharmaceuticals and ensuring their proper use. Thus, the areas where researchers can contribute to society are diverse. The role of young researchers addressing challenges by utilizing their expertise—from basic research to clinical applications—is becoming increasingly important.
At this symposium, four presenters, including students and pharmacists, will share their research outcomes. Their work spans diverse areas, from elucidating disease mechanisms underlying drug discovery to addressing challenges in pharmaceutical use in clinical settings. Specific topics include the role of prosaposin in pancreatic cancer and endothelial ERK5 in aortic diseases, as well as drug repositioning to overcome drug resistance in breast cancer. Finally, the symposium will present clinical research evaluating the applicability of the Simple Suspension Method for oral anticancer agents.
Through diverse presentations and lively discussions, this symposium aims to provide students and young researchers who will shape the future of medicine with an opportunity to gain new insights. We hope this event inspires both presenters and participants to advance their research further.
At this symposium, four presenters, including students and pharmacists, will share their research outcomes. Their work spans diverse areas, from elucidating disease mechanisms underlying drug discovery to addressing challenges in pharmaceutical use in clinical settings. Specific topics include the role of prosaposin in pancreatic cancer and endothelial ERK5 in aortic diseases, as well as drug repositioning to overcome drug resistance in breast cancer. Finally, the symposium will present clinical research evaluating the applicability of the Simple Suspension Method for oral anticancer agents.
Through diverse presentations and lively discussions, this symposium aims to provide students and young researchers who will shape the future of medicine with an opportunity to gain new insights. We hope this event inspires both presenters and participants to advance their research further.
挨拶
川端 崇義1,2(1岡山大病院薬、2岡山大院医歯薬)
[GS03-1]The role of endothelial ERK5 signaling in the onset of aortic diseases
○Shuto Itokazu1, Yuki Izawa-Ishizawa1,2, Mizusa Hyodo1, Tatsumi Miyata1, Himeno Fukuoka1, Tamami Yamao1, Kaito Tsujinaka1,3, Masateru Kondo1,3, Io Horikawa1,3, Takahiro Niimura1,4, Fuka Aizawa1,4, Kenta Yagi1,5, Kei Kawada1,3, Mitsuhiro Goda1,6, Keisuke Ishizawa1,3,4 (1. Dept. of Clin. Pharmacol. & Ther., Grad. Sch. of Biomed. Sci., Tokushima Univ., 2. Dept. of Health & Nutrition, Fac. of Human Life Sci., Shikoku Univ., 3. Dept. of Pharm., Tokushima Univ. Hosp., 4. Clin. Res. Ctr. for Dev. Ther., Tokushima Univ. Hosp., 5. Dept. of Pharm., Shimane Univ. Hosp., 6. Dept. of Clin. Pharmacol. & Ther., Grad. Sch. of Biomed. & Health Sci., Hiroshima Univ.)
[GS03-2]Prosaposin promotes the proliferation of pancreatic cancer cell lines BxPC-3
○Honoka Shibata1, Hiroaki Nabeka1 (1. Coll Pharm Sci, Matsuyama Univ)
[GS03-3]Machine learning-based discovery of YES1 inhibitors for overcoming resistance to HER2-targeted therapy
○Takayoshi Kawabata1,2, Tatsuaki Takeda2, Yuta Tanaka1, Hirofumi Hamano1,2, Yoshito Zamami1,2 (1. Dept. Pharm., Okayama Univ. Hosp., 2. Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ.)
[GS03-4]Evaluation of disintegration and enteral tube possability of oral anticancer drugs using the quick bag suspension method
○Shota Gushiken1, Mai Okada1, Manahito Aoki2,3, Manabu Amano4, Sakae Saito3, Yuriko Namiki2, Kouta Akiyama2, Mitsuhiro Sugawara2,3, Kenshi Takechi1,5, Shingo Takatori1,5 (1. Dep. Drug Info. Analysis, Coll. Pharm. Sci., Matsuyama Univ., 2. Sch. Pharm., Kitasato Univ., 3. Dep. Pharm., Kitasato Univ. Med. Ctr., 4. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 5. Dep. Clin. Pharm. Sci., Grad. Sch. Clin. Pharm., Matsuyama Univ.)
